Clinical Trials in Maryland

Showing 22401-22420 of 23,284 trials

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

NCT00000698

To determine the safety and effectiveness of intravenous ganciclovir (also known as DHPG) in the treatment of sight-threatening cytomegalovirus (CMV) retinitis in patients with AIDS. CMV retinitis is a severe vision-threatening viral infection of the retina of the eye. It occurs in patients whose immune function has been impaired and is the most common cause of blindness in patients with AIDS. Ganciclovir (GCV) improved the signs and symptoms of CMV retinitis in approximately 80 percent of the patients treated for 2 weeks, but almost all of the patients treated with GCV had a relapse after treatment was stopped. Thus, it is important to determine if GCV can be safely given over a long period of time (maintenance therapy) and if it is effective in preventing a relapse of CMV retinitis.

Cytomegalovirus RetinitisHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)

Bethesda, Maryland, United States

COMPLETEDPhase 217 miles

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

NCT00170469

This is a dose ranging study comparing different vaccine schedules of rPA vaccine, for Anthrax, to the licensed dose of AVA, another Anthrax vaccine. Safety and the capability to induce an immune response will be evaluated.

Bacillus Anthracis (Anthrax)

PharmAthene UK Limited226 participantsStarted Mar 2005

Huntsville, Alabama, United States • Mobile, Alabama, United States • San Diego, California, United States +13 more locations

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Find Trials by Condition in Maryland

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Nebulizer Intervention for Minority Children With Asthma

Idiopathic Anemia of Aging (IAA)

Phase II CT-2103/Carboplatin in Ovarian Cancer

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

The Effect of Infant Feeding on Stool Characteristics

Assessment of Whole Gut Transit Time Using the SmartPill Capsule

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss

Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction

Chemoprevention of Oral Premalignant Lesions

SLV308 for Treatment of Patients With Early Parkinson's Disease

Long-Term Follow-Up Study of Psoriasis Patients